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Resumo 
 
Introdução: Aproximadamente 1,4 milhões de indivíduos no Reino Unido sobreviveram 
a um Enfarte Agudo do Miocárdio (EAM). Aquando da alta hospitalar, são prescritos 
medicamentos de segunda prevenção. Portanto, o tempo para educar e ajustar a 
medicação para obter resultados otimizados é escasso. A eHealth tem crescido 
exponencialmente sendo vista como forma para criar proximidade entre o profissional de 
saúde e o paciente. É importante avaliar a aplicabilidade da app assim como a população 
abrangida para ser uma ferramenta válida para substituição de consultas presenciais.  
Objetivos: O objetivo principal deste projeto é desenvolver uma clínica virtual para 
contribuir de forma eficiente na prestação de cuidados de saúde e promover proximidade 
entre os profissionais de saúde. Como passo intermédio, este projeto pretende explorar a 
aplicabilidade de implementar o mesmo. O objetivo específico é avaliar a opinião dos 
pacientes sobre a utilidade e aceitabilidade de ter Clínicas Virtuais de forma a usar a 
tecnologia para melhorar a prestação de cuidados de saúde.  
Metodologia: Um questionário de autorrelato foi desenvolvido para avaliar as barreiras 
e facilidades de um acompanhamento feito em clínicas virtuais após um EAM. O 
questionário englobou perguntas sociodemográficas, avaliação da literacia em saúde e 
afirmações de forma a demonstrar a experiência dos pacientes no uso de smartphones e 
apps. Os dados foram recolhidos e analisados através do programa SPSS 25. Nesta 
análise, foi focada a validade do questionário, análise univariada e bivariada.  
Resultados: Um total de 50 pacientes participaram sendo a idade média 61 ± 14, 76% 
eram do sexo masculino e 12% do sexo feminino, 42% eram da parte Este de Londres, 
48% eram brancos e 68% tinham o ensino secundário ou menos. A maioria dos 
respondentes, (n=50;70%) consideraram que têm a habilidade para usar um smartphone, 
42% concordam que um app poderia ser um substituto para consultas presenciais, 62% 
gostariam de ter uma app para monitorizarem a sua condição e 74% concordam que ter 
acesso a um profissional de saúde através de uma app teria um grande impacto na sua 
saúde. Pacientes mais novos mostraram mais prontidão em usar a app (p< 0.001). 
Conclusão: Os dados coletados mostram potencial em ter uma Clínica Virtual para 
prevenção secundária. No entanto, são necessários mais estudos para apoiar o seu uso 
como substituto a consultas presenciais.  
Palavras-chave: EAM; Acompanhamento; Clínica Virtual; Prevenção Secundária 
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Abstract 
Introduction: Approximately 1.4 million people in the UK have survived a Myocardial 
Infarction (MI). When discharged, patients leave with a secondary prevention therapy. 
However, time to educate patients and adjust medication to an optimal treatment is 
limited. eHealth has grown exponentially being seen as a means to create proximity 
between professionals and patients. It is important to assess the feasibility of an app in 
order to be a valid replacement for face-to-face consultations. 
Objective: This project’s ultimate aim is to develop a virtual clinic to contribute to 
efficient delivery of healthcare and to promote proximity between healthcare 
professionals and patients. As an intermediate step, the current project aims to explore 
the feasibility of implementing such technology. The specific objective is to assess 
people’s opinion on the utility and the acceptability of a virtual clinic as a means to use 
technology to improve healthcare provision. 
Methods: A paper and pencil self-report questionnaire was developed to assess barriers 
and enablers of follow-up using virtual clinics, after MI.  The questionnaire comprised 
sociodemographic data, a Health Literacy assessment tool and statements to reflect 
patients’ views and experiences on the use of smartphones and applications. Data was 
collected and subsequently analyzed. Analysis was processed using SPSS 25 and focused 
on questionnaire validation, univariate and bivariate statistics. 
Results: A total of 50 patients participated, the mean age was 61 ± 14, 76% were male 
and 12% were female, 42% were from East London and 48% were white and 68% have 
a high school degree or less. The majority of respondents (n=50; 70%) consider they have 
skills to use a smartphone, 42% agree the app may be a substitute to face to face 
consultations, 62% would like to have an app to monitor their condition and 74% agree 
that having access to a healthcare professional through an app would have a great impact 
in their health. Younger patients were more prompt to use apps (p< 0.001). 
Conclusion: Data gathered showed potential of having a virtual clinical app as a 
secondary prevention follow-up. However, further studies must be developed to support 
the use of Virtual Clinic apps for future replacement of follow-up face-to-face 
consultations for secondary prevention therapy. 
Keywords: Myocardial Infarction; Follow-up; Virtual Clinic; Secondary Prevention 
Therapy 
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Chapter 1 – Introduction 
 
1.1 - Background 
According to the British Heart Foundation (BHF), in the United Kingdom (UK), 7.4 
million people live with heart and circulatory diseases, also known as cardiovascular 
diseases (CVD), being twice as many people than the ones living with Alzheimer’s 
disease and cancer. The healthcare cost of CVD is estimated to be 19 billion pounds per 
year and accounting for a quarter (28%) of all UK deaths (British Heart Foundation., 
2019b). 
In august 2019, in the UK, 280 daily hospital admissions were due to a myocardial 
infarction (MI), 225 corresponding of England admissions (British Heart Foundation., 
2019b, 2019a).  
Approximately, 1.4 million people in the UK have survived a myocardial 
infarction (MI), and England accounts for 1.1 million of those people. (British Heart 
Foundation., 2019b, 2019a)  
When discharged, patients leave with a secondary prevention therapy post 
myocardial infarction. As stated by the European Society of Cardiology (ESC), early 
discharge is appropriate in low-risk patients, preferably between 24h-48h. Thus, the time 
to educate the patient and adjust the medication to an optimal treatment plan is limited 
(Ibanez et al., 2018). It would be important to have tools that would help healthcare 
professionals to have regular follow-up of patients remotely.  
In a world where technology is evolving at a fast pace it is vital that healthcare 
services keep up to date with evolution and keeps reinventing themselves using 
technology to its advantage. eHealth has been shown to have an immense growth in the 
last two decades and the World Health Organisation (WHO) believes that it’s not possible 
to achieve universal health coverage (UHC) without its use (World Health Organization, 
2016).  
eHealth has been crucial for knowledge management and quality of care as well 
as promoting health and preventing diseases (Galbán & Vidal, 2019). It is possible to 
increase the access to health services through technology, for instance with smartphones.  
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Their use has been growing rapidly with more than 2.2 billion mobile 
subscriptions globally (World Health Organization, 2016). mHealth or mobile health is 
defined by WHO as the mobile usage for healthcare services such as monitoring patients, 
appointments reminders, telephone helplines, access to patient information which have 
been growing rapidly in a global scale (World Health Organization, 2016).  
Notwithstanding, the use of mobile applications for healthcare purposes is still 
very scarce in the majority of countries, particularly if the application is designed for a 
specific purpose like post myocardial infarction follow-up. Ensuring patients have the 
necessary knowledge to use a smartphone and take the most advantages of the app is a 
vital step to the success of mHealth in the future. 
 
1.2 - Necessity 
The use of technology in healthcare has grown exponentially and continues to grow 
with more frequency. It can be seen as a means to facilitate and create proximity between 
the healthcare professional and the patient.  
Having an app supporting a patient condition would not only be beneficial to the 
patient but also to the healthcare system. However, in order to guarantee that the app is 
successful, it is essential to make sure that patients have the right level of eHealth literacy 
to use this service to their advantage as well as being receptive to the idea of having an 
app to monitor their condition. 
Myocardial infarctions can affect people from all age ranges but is more common 
amongst elder people (> 65 years old), accounting for 60% of hospitalizations due to acute 
coronary syndromes (ACS) (Engberding & Wenger, 2017).  
Nowadays, people are expected to keep up with technology. However, this becomes 
a harder task for the elderly since they have more difficulty adapting and adjusting to 
these new technologies given their limited technological knowledge (Zoe, 2012). 
Having an app monitoring a patient post myocardial infarction has numerous 
benefits. Nevertheless, it is important to assess the feasibility of the app as well as the 
populational range it can reach, so that it becomes, a valid replacement for face to face 
consultations. 
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1.3 - Study Setting 
 This study was conducted at St. Bartholomew’s Hospital in London, UK. St. 
Bartholomew’s Hospital is one of the five hospitals within Barts Health NHS Trust, the 
country’s largest trust covering a population of 3 million people across London and Essex. 
(Barts Health NHS Trust, n.d.-a) 
This hospital is renowned by their cancer and cardiac care centres of excellence, 
Barts Cancer Centre and Barts Heart Centre. The Barts Heart Centre (BHC) is Europe’s 
largest specialised cardiovascular centre which aims to save more than 1000 lives a year 
being one of the busiest myocardial infarction centres in the UK. (Barts Health NHS 
Trust, n.d.-b) 
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Chapter 2 – Contextualization 
 
2.1 - Acute Coronary Syndromes (ACS) 
The term ACS is used to describe symptoms when there is a sudden obstruction 
or reduction of blood supply through the coronary arteries to the myocardium or a section 
of the heart also known as heart ischaemia (Gavalova, 2016).  
Acute coronary syndromes can be divided into three clinical patterns; two 
different forms of MI: non-ST elevation myocardial infarction (NSTEMI) and ST 
elevation myocardial infarction (STEMI) and a third form, unstable angina, a more 
serious type of angina. (Keenan, Khatib, Lock, Ward, & Warren, 2012) 
 
2.1.1 - Epidemiology 
In a global scale, ACS is responsible for being the higgest mortality cause as well 
as loss of disability adjusted life years (DALYS). Seven million deaths and 129 million 
DALYs a year are due to ACS (Cherkasov et al., 2015).  
In the United Kingdom, they are responsible for 280 hospitalizations per day 
costing 9 billion pounds a year (British Heart Foundation., 2019b). Furthermore, over 
327.000 DALYS are lost due to ACS per year causing the individuals and their families 
to have a reduced quality of life (Charles River Associates, 2009).  
Around 1.9 million people in England live with ACS being one of the lead causes 
of premature death. Every 6 minutes, a new patient is admitted due to a myocardial 
infarction and it is believed that around 1.1 million people in England have survived a 
myocardial infarction (British Heart Foundation., 2019a). Around 40 percent of those 
admissions were STEMI and 60 percent due to NSTEMI (Gavalova, 2016).  
In the past two decades, the number of admissions due to STEMI have decreased 
and hospital mortality has decreased from 20 percent to 5 percent mainly as a result of an 
improvement in patient care, specialist follow-up and cardiac rehabilitation which results 
in quality of life improvements in patient and leads to better results (Gavalova, 2016). 
Another important reason is the increased access and faster uptake of drug treatment. 
(National Institute of Health and Care Excellence, 2013).  
 




Chapter 2 - Contextualization 
 21 
In this type of ACS, similarly to a NSTEMI, there is a partial blockage of the 
artery creating a ‘stuttering’ pattern related to the width of the clot. Therefore, the blood 
flow is dependent of the clot causing an erratic pattern without causing myocardial 
damage or troponin changes (Keenan et al., 2012). 
Although there are crucial differences between unstable angina and NSTEMI, 
these are both often classified under a non-ST elevation ACS (NSTE-ACS). 
 
2.1.5 - Symptoms and Diagnosis  
Symptoms  
 In case of an ACS it is crucial to recognize the symptoms early on. It is common 
to mistake MI symptoms for respiratory or gastrointestinal issues. When experiencing 
any of the symptoms it is vital that the help of healthcare professionals is provided. When 
experiencing an ACS, people can present  several number of symptoms (NICE guidelines, 
2010): 
- Chest pain: assure that it is cardiac pain during for more than 15 minutes. It 
may irradiate to either or both arms, neck, throat, jaw, teeth or back. It is 
relevant to understand the history of the chest pain, the risk factors the patient 
may present, any previous CVD or previous chest pain reports.  
- Patients may experience nausea and vomiting, sweating, breathlessness or all 
of them simultaneously. 
- Exacerbation of the chest pain or worsening of stable angina resulting in 
persistent chest pain with little or no effort. The exacerbation can also be 
linked to fluid retention or haemodynamic instability.  
 
Diagnosis 
 To diagnose with accuracy the type of ACS the patient is suffering, there are a 
few steps that need to be taken as soon as the patient arrives to the hospital (Ibanez et al., 
2018). After identifying the common symptoms of an ACS, it is necessary to look for the 
signs. For that reason, the patient is submitted to an electrocardiogram and blood tests to 
ensure healthcare professionals of the accurate ACS type. 
 
Electrocardiogram 
 The electrocardiogram (ECG) is used to provide information from the heart, when 
there is cardiac excitation through potential differences. From the ECG it is possible to 
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Source: (Pleister, Selemon, Elton, & Elton, 2013) 
 
 Notwithstanding, the ECG can be hard to analyse and get a precise diagnose as 
patients might have other abnormalities and for that reason it is also important to resort 
to an emergency coronary angiography and to a Percutaneous Coronary Intervention 
(PCI). 
Cardiac Markers 
 For a complete formal risk assessment of the condition, it is necessary to conduct 
blood tests to look for biochemical markers of cardiac damage (National Institute for 
Health and Care Excellence (NICE), 2010; National Institute for Health and Care 
Excellence, 2014).  
 It is possible to assess injury through biomarkers such as cardiac troponin (cTn) 
or creatine kinase MB fraction (previously used diagnose biomarker) when their blood 
levels are increased. Cardiac troponin can be divided into three separate structural 
proteins, troponin T, C and I. Cardiac troponin I and T exist in the contractile cells of the 
myocardium and are specific to the heart muscle. Thus, when these two types of troponin 
Figure 6 - ECG Patterns 
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are elevated in blood tests, it is commonly related to myocardial muscle damage  (NICE 
guidelines, 2010; Thygesen et al., 2012).  
 Troponin levels tend to raise four hours after the first onset symptom and remain 
in elevated for the duration of two weeks making it an excellent biomarker for cardiac 
damage. When measuring troponin levels, it is necessary to complete this procedure twice 
to look for signs of further damage (continuous raising levels of troponin) or a sign that 
the condition is being resolved (no troponin levels elevation) (NICE guidelines, 2010).   
 Tests such as glucose, haemoglobin and creatinine should also be taken into 
account when dealing with ACS. 
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2.2 - Acute Management of ACS 
 When dealing with an ACS, the first stage is to take a 12-lead ECG to start 
managing the problem at the earliest. Afterwards, it is vital to assess the level of pain and 
offer pain relief such as (Herlitz, Hjalmarson, & Waagstein, 1989): 
• glyceryl trinitrate (GTN) spray: the dose should be between 0.3-1mg to create 
vasodilatation of the coronary arteries to decrease myocardial oxygen 
consumption levels, myocardial preload,  left ventricle diastolic volume and 
increase coronary collateral flow (Roffi, Patrono, Collet, Mueller, Valgimigli, 
Andreotti, Bax, Borger, et al., 2016).  
• Intravenous opioids: morphine is commonly use on acute management; the dose 
varies between 5-10 mg administered regularly following patient needs. 
Morphine should be considered specially if an MI is suspected (NICE, 2010). 
Since morphine has side effects like nausea and vomiting, it is important to 
consider and antiemetic when administering the first opioid dose to prevent them, 
normally patient are given metoclopramide (Keenan et al., 2012).   
 
Subsequently, the patient is offered a loading dose of Aspirin (300 mg) to minimize 
or prevent heart damage unless they are allergic or hemorrhaging. Aspirin in this dose 
will act as an antiplatelet and prevent or slow down the creation of atheromas (NICE 
guidelines, 2010).  
If necessary, oxygen can be used in patient at risk of CO2 retention. People with 
Chronic Obstructive Pulmonary Disease (COPD) should be specially taken into account 
when measuring oxygen saturation (National Institute for Health and Care Excellence, 
2014). When arriving to the hospital, the patient is direct to a specific acute ward in order 
to conduct further testing and establish the treatment strategy, a coronary angiography is 
important to assess the severity of the coronary disease commonly followed by PCI or 
angioplasty, a reperfusion therapy to clear the artery blockage and return blood flow to 
the heart (Figure 7). 
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2.3 - Secondary Prevention Therapy 
 When recovering and going through cardiac rehabilitation, it is crucial that the 
patient understands what he/she has been through and how to avoid having a second 
cardiovascular event. When managing patient with diagnosed NSTEMI and Unstable 
Angina, it is important to evaluate the future risk of having another event of this nature 
or evolving to a STEMI. This is established using risk scoring systems that allows to 
predict 6-month mortality for clinical management (National Institute for Health and Care 
Excellence, 2014).  
Nevertheless, all ACS patients are guided on how to tackle risk factors and given 
a secondary prevention drug therapy following The National Institute for Health and Care 
Excellence (NICE) guidelines (NICE Pathways, 2019). 
  
2.3.1 - Risk Factors Management  
 There are several preventable risk factors that when well managed can be of 
substantial help when dealing with cardiac complications. However, these sudden 
changes to a person’s lifestyle may come as a shock so it is essential that the changes are 
made gradually and realistically tailored to the patient in order to achieve optimal results 
and permanent changes (NICE, 2013). 
 
 The European Society of Cardiology (ESC), developed guidelines on how to 
prevent cardiovascular diseases. Some key interventions rely on alcohol and smoking 
cessation, diet control and weight loss, exercise, hypertension management and drug 
therapy adherence.  
 
Alcohol and Smoking cessation 
Alcoholic beverages when highly and regularly consumed can be associated with 
a high risk of CVD. There are scores used as screening tools (AUDIT-C) to assess the 
risk of affecting a person’s health commonly used when gathering patient information. 
This way, healthcare professionals can advise patients to moderate their consumption to 
the recommended levels and help them understand giving them The Brief Advice on 
hazardous and harmful drinking. On the other hand, smoking has a major role on CVD as 
it has a strong pro-thrombotic effect and thus being the most cost-effective approach of 
prevent CVD. There are a few interventions that can be made for smoking cessation such 
as Nicotine Replacement Therapy (NRT), brief interventions and assistance, amongst 
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other. The smoking cessation should start in hospital and continued as follow-up since 
the benefits have been proven by several studies (Piepoli et al., 2016). 
 
Diet Control, Weight loss  
When gathering patient information, is it necessary to calculate their Body Mass 
Index (BMI) since being overweight (BMI >25 kg/m2) is strongly linked to all-cause 
mortality (Ibanez et al., 2018). This allows for a personalised dietary intervention. 
According to the ESC guidelines, a Mediterranean diet is recommended as well as 
reducing salt intake. Along with weight loss, dietary interventions have shown to have 
beneficial effects on CVD risk factors, for instance, Diabetes mellitus, hypertension and 
hyperlipidaemia.  
 
Exercise  
Part of the cardiac rehabilitation programme is to engage into a few activities adapted 
to the patient. This has shown beneficial physiological effects on cardiac rehabilitation 
improving all-cause and CVD mortality by 20-30% (Sattelmair, Pertman, Ding, Kohl, & 
Haskell, 2011). 
 
 
Hypertension Management  
The prevalence of hypertension is extremely high being the leading risk of CVD 
accounting for 9.4 million deaths (Stephen S Lim‡, Theo Vos, Abraham D Flaxman, 
Goodarz Danaei et al., 2012). This is a preventable risk factor that must be controlled if 
the previously mentioned interventions are followed. When a person is diagnosed with 
high blood pressure, he/she should be directed to a hypertension clinic and should be 
checked periodically by a healthcare professional controlling blood pressure as well as 
the suitability of pharmacotherapy scheme. 
 
2.3.2 - Pharmacological Therapy 
 Additionally, to the non-pharmaceutical interventions, all ACS patients are 
offered secondary prevention therapy. According to ESC Guidelines, ACS can be 
pharmacologically managed with dual antiplatelet therapy (DAPT), a beta-blocker, a 
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statin and an angiotensin converting enzyme (ACE) inhibitor or angiotensin-II receptor 
blocker (ARB) (Ibanez et al., 2018; NICE, 2013).  
 The treatment is started during the patient’s stay at the hospital and doses should 
be up titrated as much as possible before patient discharge to attempt to achieve optimal 
pharmacological therapy. Both patient and General Practitioner (GP) must be given a 
discharge summary letter with clear instructions on monitoring risk factors regularly and 
medication information and dose up titration (NICE Pathways, 2019).   
 
Dual Antiplatelet Therapy (DAPT) 
 This dual therapy is composed by Aspirin and a P2Y12 inhibitor, such as 
Clopidogrel, Prasugrel or Ticagrelor. The benefits of dual antiplatelet following an ACS 
was established by the CURE, 1 COMMIT/CCS-28 and CLARITY-TIMI 289 trials. 
Aspirin in long term prevention, the dose should be between 75-100 mg once a day should 
indefinitely and in case of intolerance, switch to Clopidogrel. The second antiplatelet has 
been shown to reduce 1-year incidence of cardiovascular disease by approximately 20% 
compared to Aspirin alone (John Wilson, E. Newby, Dawson, & Irving, 2017).  
Normally DAPT is continued for a period of 12 months continuing only with 
Aspirin after that period. However, this will depend of the patients bleeding risk, type of 
intervention (PCI or other) and the type of stenting used (Ibanez et al., 2018). 
 When using DAPT, it is important to have prophylactic dose gastrointestinal 
protection given to the patient. Commonly, healthcare professionals resort to proton pump 
inhibitors (PPI) for patients receiving DAPT in older patients (>65 years old), patients 
with gastrointestinal bleeding risk or helicobacter pylori infection or patients using anti-
inflammatory or steroid medication. Lansoprazole is the most used PPI since 80 mg of 
Omeprazole reduces Clopidogrel effects and thus its use is discouraged ((MHRA), 2010; 
Baxter, 2006). 
 
Beta-blockers 
 Beta-blockers, like bisoprolol, metoprolol, atenolol and others, are used to take 
the pressure of the heart and lower blood pressure consequently causing lower heart rate, 
reduction of oxygen consumption and myocardial contraction. They have anti-arrhythmic 
properties that may reduce ventricular arrhythmias. Its long-term use benefits have very 
strong evidence and its recommended that the treatment is started as soon as the patient 
is stable. The first dose given should be low and gradually up titrated to the maximum 
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dose tolerated by the patient (NICE, 2013). The treatment should take at least one year to 
allow the heart to heal from the stress caused by the cardiac event and the patient might 
fell some side effects such as tiredness when starting it.   
 
Statins 
 Statins are also known as lipid lowering therapy. Its benefits have been 
demonstrated extensively and have shown vital outcomes when started early and 
intensively in ACS. These are used to lower cholesterol levels and also due to their anti-
inflammatory properties. The levels are checked when the patient is admitted to the 
hospital and patients are then started on a high intensity statin, for instance, atorvastatin 
and rosuvastatin always taking into account their preference, reaction to side effects like 
myopathy and hepatotoxic properties (Deanfield & Al, 2015; Yusuf, 1988). No up 
titration is need for high intensity statin treatment and its common practise to medicate 
the patient with atorvastatin 80 mg once a day. It is crucial that the monitoring of statin 
treatment occurs regularly and accompanied by the patient’s GP for monitoring or any 
side effects complaints. Dietary and lifestyle recommendations also take part in getting 
optimal results with statins (National Institute for Health Care Excellence, 2016). Liver 
function test should be run before starting a statin and measured following three months 
and one year later. 
 
Angiotensin converting enzyme (ACE) inhibitors 
 ACE inhibitors or ARB’s are part of the patient’s treatment and should be offered 
post MI as soon as they are haemodynamically stable and with good renal function. 
Studies have confirmed the safety and benefits of starting an ACE inhibitor or ARB, 
having a small however significant reduction in 30-day mortality, especially in the first 
week of treatment (Infarction, 1998; “ISIS-4: A randomised factorial trial assessing early 
oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients 
with suspected acute myocardial infarction,” 1995). This medication should be continued 
indefinitely and up titrated to maximum tolerated dose by the patient in 24h intervals, 
when this is not possible in hospital, up titration could take up to four to six weeks after 
hospital discharged and should be continued by the patients GP. Blood pressure, renal 
function and serum electrolytes should be measured in advance and redone after starting 
treatment and one year after and keep monitoring at least once a year (NICE, 2013).   
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2.3.3 - Adherence and Follow-up 
 Local research showed that high adherence to secondary prevention medication is 
strongly linked to prevention of future MI’s. Hence, it is crucial to keep up with these 
patients to prevent further events from happening in the future when there is transition of 
care. A multi-disciplinary approach is important in cardiology care to improve medication 
management knowledge as well as enhance post discharge care (Anchah et al., 2017).  
 As previously stated, most of medication taken need close monitoring and dose 
adjustments so adherence to therapy and follow-up is crucial to continue a successful 
second prevention therapy along with risk factor management. With medication 
optimization, the healthcare professionals want to achieve the maximum benefit for 
patients (Royal Pharmaceutical Society, 2013). Adhering to treatment has been shown to 
lower mortality and morbidity and increase patient well-being. Plus, there is evidence that 
not complying with the treatment causes a 10% to 40% risk of rehospitalization and an 
increased risk of mortality by 50% to 80% (Ho et al., 2008). 
 According to an observational cohort study, after following patients after 6 months 
post discharge with secondary prevention therapy, shows that 41.8% were non-adherent 
(Brieger et al., 2018). It is vital to create proximity between patients and healthcare 
professionals in order to improve adherence numbers particularly in the first month of 
treatment (Keenan et al., 2012).  
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Chapter 3 – Aims and Research Questions 
 
3.1 - Aim 
The aim of this project is to determine if a virtual clinic through an app would be 
beneficial as a substitute for regular follow-up face to face consultations. To reach this 
aim, the established strategy was to question patients about the feasibility of having a 
mobile application to follow their condition and analyse their willingness of having a 
remote follow-up instead of a face to face consultation with the cardiac specialist for the 
hospital.  
 
3.2 - Objectives 
The ultimate objective of this project was to assess the willingness of patients for 
having an app to monitor their condition remotely post MI. Specific objectives set to 
achieve the aim were: 
- To evaluate the patients’ perspective of having access to remote follow-up 
through a virtual clinic, by questioning their willingness. 
-  To judge the feasibility of implementing such virtual clinics, by accessing 
patient and environment-related factors.  
 
3.3 - Research Questions 
On this basis, the following specific research questions were developed:  
1. Does gender influence the willingness to use an app? 
2. Does age influence the promptness of using an app? 
3. Does age influence the ability to use an app? 
4. Does education influence the promptness of using an app? 
5. Does education influence the ability to use an app? 
6. Does educational level influence digital and health literacy? 
7. Do patients deem the app an equivalent substitute to face to face consultations? 
8. Are patients willing to help the clinician with the data needed for a follow-up 
consultation? 
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3.4 - Hypothesis Formulation 
 
In order to analyse the data of this study, the following hypothesis were formulated. 
 
3.4.1 - Gender’s Influence on the Willingness to use a Virtual Clinic App 
 
Hypothesis 1: Gender influences the ability to use apps. 
H0 – Males will tend to score low on the component Ability. 
H1 –Males will tend to score high on the component Ability. 
 
Hypothesis 2: Gender influences the promptness to use apps. 
H0 – People over 65 will tend to score low on the component Promptness. 
H1 – People over 65 will tend to score high on the component Promptness. 
 
 
3.4.2 - Age’s Influence on the Willingness to use a Virtual Clinic App 
 
Hypothesis 3: Age influences the ability to use apps. 
H0 – People over 65 will tend to score low on the component Ability. 
H1 – People over 65 will tend to score high on the component Ability. 
 
Hypothesis 4: Age influences the promptness to use apps. 
H0 – People over 65 will tend to score low on the component Promptness. 
H1 – People over 65 will tend to score high on the component Promptness. 
 
3.4.3 - Education’s Influence on the Willingness to use a Virtual Clinic App 
 
Hypothesis 5: Education Level influences the ability to use apps. 
H0 – People with level of education of bachelor’s degree or above will tend to score 
low on the component Ability. 
H1 – People with level of education of bachelor’s degree or above will tend to score 
high on the component Ability. 
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Hypothesis 6: Education Level influences the promptness to use apps. 
H0 – People with level of education of bachelor’s degree or above will tend to score 
low on the component Promptness. 
H1 – People with level of education of bachelor’s degree or above will tend to score 
high on the component Promptness. 
 
Hypothesis 7: Health literacy is influenced by education level. 
H0 – Almost always adequate literacy is not related with a level of education of bachelor’s 
degree or above. 
H1- Almost always adequate literacy is related with a level of education of bachelor’s 
degree or above. 
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Chapter 4 – Methodology 
 
4.1 - Study Design and Duration  
An observational and cross-sectional study was developed, where patients were 
accessed in one single moment in time. This study took place between June and August 
2019. The study can be divided in two different periods.  
At a first phase, the questionnaire was developed and piloted amongst a five 
randomly selected patients notwithstanding, no significant changes were made to achieve 
the final version.  
Following face validation by the research team, data collection was initiated and 
lasted three weeks between 24th June and 12th July 2019.   
 
4.2 - Population 
 The study population was selected from the ward 3A East of St. Bartholomew’s 
Hospital. This ward receives patients admitted with acute cardiology emergencies 
predominantly with ACS. To select patients, it was necessary to establish the ones that 
were suitable and adequate to this particular subject of study. 
A priori sample size estimation was not possible since it was not conceivable to 
select more patients than those present in the 3A East ward, thus, after discussing the 
matter with the expert panel, the conclusion reached was to recruit all patients meeting 
the inclusion criteria during the study period the sample size subsequently.  
 
4.2.1 - Inclusion and Exclusion Criteria  
This study aimed to include every patient diagnosed with an ACS however, this 
was not possible hence, the need to create exclusion criteria. 
 
Inclusion criteria comprised:  
- Myocardial Infarction: STEMI; 
- Myocardial Infarction: NSTEMI; 
- Recurrent ACS. 
 
Exclusion criteria included: 
- Stable angina; 
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- Unstable angina; 
- a signed Do Not Attempt Resuscitation form (DNAR); 
- not physically or mentally capable; 
- weekend patients.  
 
4.3 - Data Collection 
 To collect the necessary data, a questionnaire was developed by the main 
researcher with the help of a panel of 3 experts in research and in Cardiology. Based on 
the Bite-Size Guide To Patient Insight: Writing An Effective Questionnaire (NHS, 2018), 
the structure and tone of the questionnaire was established.  
Subsequently, the questionnaire was divided into three different parts, 
sociodemographic question, opinion assessment questions and health literacy assessment. 
(Appendix 1)  
Following the willingness of the patient to participate in this study, the 
questionnaire was handed out to the patients in order for them to fill it in autonomously. 
 
4.3.1 - Sociodemographic Data 
 The sociodemographic questions consisted of: 
- Age 
- Gender 
- First three letters of the Post Code 
- Ethnic Origin 
- Educational Level  
- Employment Status 
- Mother Tongue 
- Existence of a Carer 
 
The options in the questions from this section of the questionnaire were 
formulated based on the National Health System (NHS) Data Dictionary (NHS, n.d.). 
 
4.3.2 - Attitude Measurement 
 The data collection consisted of questions developed using the Likert Scale in 
order to assess the predisposition of using the app and the ease to use technology for the 
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purpose suggested. It was developed entirely by the panel of experts along with the main 
researcher with the aim of creating questions designed specifically for this study. The 
Likert Scale is often used to get feedback and collect people’s opinions on a matter 
(Sullivan & Artino, 2013). The type of Likert Scale chosen ranges from “Strongly 
Disagree” to “Strongly Agree” allowing the respondent to freely choose in which degree 
they agree or disagree with the statements. It was decided to vary between positive and 
negative statements so as to avoid sleepers’ questions and keep the patient’s attention 
throughout the questionnaire. 
 
4.3.3 - Newest Vital Sign (NVS) Score  
 To evaluate Health Literacy, a third part was created based on the Newest Vital 
Sign (NVS) developed with the purpose of evaluating health literacy of patients. It is a 
simple and quick tool to assess if the patient is able to understand and act upon health 
information (Pfizer, 2011). (Appendix 2) 
 This tool consists of 6 questions based on a nutrition label of an ice cream. After 
answering, patients are given a score, from 0 to 6 evaluating the number of correct 
answers (Table 1).  
 
Score Indication 
0-1 High likelihood (50% or more) of limited literacy 
2-3 Possibility of limited literacy 
4-6 Almost always indicates adequate literacy 
Table  1 - Newest Vital Sign Score 
Source: Adapted from Pfizer, 2011 
4.4 - Statistic Analysis 
Data collected were analysed using descriptive and bivariate statistics. Descriptive 
analysis focused on absolute and relative frequencies, and on dispersion measures such 
as means, median and standard deviation. Kolmogorov-Smirnov was used to ascertain 
the distribution of all variables to decide on the use of parametric or non-parametric tests. 
Bivariate analysis was used to explore associations between variables. Spearman test, 
Mann-Whitney test and chi-square test were used, respectively, in the presence of two 
continuous variables, continuous categorical variables, and two categorical variables. 
Data were presented using graphs and tables according to the type of data gathered. IBM 
Statistical Software Package for Social Sciences (SPSS) version 25 was used.  
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4.5. - Ethics and Confidentiality Issues 
 
This study complied with all the requirements established by the Helsinki 
declaration, namely the respect for patient’s autonomy and right to deny participation. 
Patients were informed about the processes followed to ensure the respect for their 
anonymity and confidentiality of their data. The project was submitted to the Clinical 
Effectiveness Unit (CEU) and approved under the protocol number 7983 (Appendix 1). 
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Chapter 5 - Results 
 
5.1 - Sample Characteristics 
Between the 24th June 2019 and 12th July 2019, 55 patients were admitted 3A East 
ward. Five patients did not meet the inclusion criteria and were excluded. The remaining 
50 accepted to participate in the study. 
 
Sociodemographic Data 
 Among the 50 respondents admitted with a myocardial infarction, 38 were male 
(76%) and 12 were female (25%). The mean age was 61 (± 14) years old, ranging from 
34 to 87, 64% classified in the young age group (<65).   
 The sample characteristics are shown in table 2. Of highlight, 42% of respondents 
were from East London and 48% where white which comprises White British, White 
Irish, White Scottish. Concerning education, 68% of respondents had a High School 
degree. Regarding employment, 62% of respondents are part of England’s active 
population and the majority of respondents had English as their mother tongue (74%). No 
respondents were cared for professionally but were cared for by an informal carer (44%) 
thus, 56% of them were not cared for. Vis-à-vis Health Literacy, 32% had results that 
show almost always indicates adequate literacy 
Gender 
 Frequency Percentage (%) 
Male 38 76 
Female 12 24 
Other 0 0 
Total 50 100 
Age 
Mean age 61 
Standard Deviation ± 14 
Maximum 87 
Minimum 34 
Age Group 
 Frequency Percentage (%) 
Young (<65) 32 64 
Old (>65) 18 36 
Total 50 100 
Postcode 
 Frequency Percentage (%) 
South 2 4 
East 21 42 
North 14 28 
Outside of London 9 18 
Omitted 4 8 
Total 50 100 
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Ethnicity 
 Frequency Percentage (%) 
Asian 18 36 
White 24 48 
Black 5 10 
Other 3 6 
Total 50 100 
Education 
 Frequency Percentage (%) 
Less than a high school diploma 16 32 
High school Degree 18 36 
Bachelor’s Degree 7 14 
Master’s Degree 2 4 
Doctorate 2 4 
Other 3 6 
Omitted 2 4 
Total 50 100 
Employment Status 
 Frequency Percentage (%) 
Unable to work 2 4 
Employed for wages 20 40 
Retired 17 34 
Self-employed 11 22 
Total 50 100 
Native Language and Level of English 
 Frequency Percentage (%) 
English 37 74 
Other: Very well 4 8 
Other: Well 7 14 
Other: Not well 1 2 
Other: Not at all 1 2 
Total 50 100 
Carer 
 Frequency Percentage (%) 
No Carer 28 56 
Professional Carer 0 0 
Informal Carer 22 44 
Total 50 100 
Health Literacy (NVS) 
 Frequency Percentage (%) 
High likelihood (50% or more) of 
limited literacy 14 28 
Possibility of limited literacy 15 30 
Almost always indicate adequate 
literacy 16 32 
Omitted 5 10 
Total 50 100 
Table  2 - Sociodemographic Data 
mHealth and Patient Centered Care Data  
Among the 50 respondents, 76% owned a smartphone. Although 70% considered 
they did not need any support to use it, 18% believed they needed help using a smartphone 
and had someone to do it and 12% believed they needed help but did not have anyone to 
assist them (Table 3). 
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Smartphone 
 Frequency Percentage (%) 
Yes 38 76 
No 12 24 
Total 50 100 
Having someone to help using a smartphone 
 Frequency Percentage (%) 
No 6 12 
Yes 9 18 
Omitted 35 70 
Total 50 100 
Table  3 -Smarphone Data 
With the purpose of empowering patients to take part in their healthcare, there was 
the need to assess if respondents were willing to cooperate with the healthcare 
professional. Data shows that 44% of respondents own a Blood Pressure (BP) machine. 
Among the 56% who did not own a machine, 82% stated they were willing to buy one. 
Furthermore, it was asked if respondents were willing to go to their General Practitioner 
(GP) for regular blood tests and 92% confirmed their willingness to do so. (Table 4) 
 
Owning a BP Machine  
 Frequency Percentage (%) 
Yes 22 44 
No 28 56 
Total 50 100 
Willingness to buy a BP machine 
 Frequency Percentage (%) 
No 5 18 
Yes 23 82 
Total 28 100 
Willingness to go to the GP for Blood tests 
 Frequency Percentage (%) 
Yes 4 8 
No 46 92 
Total 50 100 
Table  4 - Patient Centered Care Data 
From the Likert Scale statements, the data was gathered and laid out in a table 
with the correspondent statements (Table 5).  
From the statements used, the following information stood out, 70% of respondents 
believe they have the technological skills to use a smartphone, 68% states to use them on 
a daily basis, 62% are familiar with apps and 52% disagree that apps are hard to use. 
Amongst respondents, 58% stated to use their smartphone to search for health subjects 
online. Respondents were equally divided into those that already have a health app 
downloaded and those that do not have any.  
The Feasibility Of Implementing Virtual Clinics As Follow-Up Of Secondary Prevention Post Acute Myocardial 
Infarction 
 
 44 
Concerning condition monitoring, 62% would like to have an app to monitor their 
condition and 74% agree that having access to a healthcare professional through an app 
would have a great impact in their health. Regarding their follow-up, 74% of the 
respondents would prefer being followed by a cardiac specialist from the hospital. In 
terms of preferences for remote monitoring, 42% stated they would find video 
consultations acceptable, whereas 34% were undecided. Having a specialist from the 
hospital to follow-up regularly was considered important for 88% of the respondents and 
66% agree that they would be happy to have follow-up through an app if it meant a 
quicker and more frequent follow-up. Plus, if given the support to use the app, 81% of 
the respondents would agree to use an app for follow-up.  
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1. “I have the technological skills to use a smartphone.” 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 17 18 6 2 7 50 
Percentage (%) 34 36 12 4 14 100 
2. “I use my smartphone regularly, on a daily basis” 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 22 12 4 5 7 50 
Percentage (%) 44 24 8 10 14 100 
3. “I am familiar with smartphone applications (app)” 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 16 15 7 3 9 50 
Percentage (%) 32 30 14 6 18 100 
4. “I find apps hard to use so I don’t have any on my smartphone.” 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 7 9 8 8 18 50 
Percentage (%) 14 18 16 16 36 100 
5. “I use my smartphone/computer to research health related subjects on the internet.” 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 13 16 6 6 9 50 
Percentage (%) 26 32 12 12 18 100 
6. “I have Health Apps installed on my smartphone.” 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 8 8 9 11 14 50 
Percentage (%) 16 16 18 22 28 100 
7. “I would be happy to have an app to monitor and support my condition.” 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 17 14 10 4 5 50 
Percentage (%) 34 28 20 8 10 100 
8. “I believe that having access to a healthcare professional through an app would have a 
great impact on my health.” 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 17 20 10 1 2 50 
Percentage (%) 34 40 20 2 4 100 
9. “I would prefer being followed-up by a cardiac specialist from hospital than my general 
practitioner (GP).” 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 25 12 9 1 3 50 
Percentage (%) 50 24 18 2 6 100 
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10. “A consultation through an app (video consultation) would more be acceptable 
compared to a face to face appointment.” 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 12 9 17 3 9 50 
Percentage (%) 24 18 34 6 18 100 
11. “Having regular follow-up from a specialist is important to me following my hospital 
admission.” 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 25 19 4 1 1 50 
Percentage (%) 50 38 8 2 2 100 
12. I would be happy for my specialist follow-up care to take place through an app if it 
offered more frequent or quicker follow up. 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 15 18 11 4 2 50 
Percentage (%) 30 36 22 8 4 100 
13. I would be willing to use an app if I was given support on how to use it. 
 Strongly Agree Agree Undecided Disagree Strongly Disagree Total 
Frequency 18 23 3 4 2 50 
Percentage (%) 35 46 6 8 4 100 
Table  5 - Qualitative Data 
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Hypothesis 7 
For this hypothesis, since the variables are non-parametric, when correlating 
Education Level with Health Literacy the Chi-Square test was used. Respondents with 
less than a university degree showed more possibility of limited literacy (71%) whereas 
respondents with a university degree or higher had almost always adequate literacy 
(67%). Despite with a clear tendency (Table 10), the association between these two 
variables was not significant (Fisher’s Exact Test p-value= 0.057). 
 
 
 
  
 
 
  
Health Literacy 
Total p-value Limited literacy or possible limited literacy 
Almost always 
adequate literacy 
Education 
Level 
Less than a 
bachelor's 
degree 
Frequency 22 9 31 
0.057 
Education Level (%) 71% 29% 100% 
Health Literacy (%) 88% 60% 76% 
More than 
bachelor's 
degree 
Frequency 3 6 9 
Education Level (%) 33% 67% 100% 
Health Literacy (%) 12% 40% 24% 
Total 
Frequency 25 15 40 
 Education Level (%) 63% 37% 100% 
Health Literacy (%) 100% 100% 100% 
Table  10 - Education Level's Influence Health Literacy 
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5.4.1 - Hypothesis 
 
Hypothesis 1: Gender influences the ability to use apps. 
H0 – Males will tend to score low on the component Ability. 
H1 –Males will tend to score high on the component Ability. 
 
It is not possible to reject H0 since the Mann- Whitney Test significance was p = 0.594 
which means that H1 is false hence, there is no gender influence on the ability of app use. 
 
Hypothesis 2: Gender influences the promptness to use apps. 
H0 – People over 65 will tend to score low on the component Promptness. 
H1 – People over 65 will tend to score high on the component Promptness. 
 
It is not possible to reject H0 since the Mann- Whitney Test significance was p = 0.923 
which means that H1 is false hence, there is no gender influence on the promptness of app 
use. 
 
Hypothesis 3: Age influences the ability to use apps. 
H0 – People over 65 will tend to score low on the component Ability. 
H1 – People over 65 will tend to score high on the component Ability. 
 
It is possible to reject H0 since the Spearman Test significance is p <0.001 and a 
component correlation of -0.552 which means that H1 is true, so age influences the ability 
of app use and it is inversely proportional.  
 
Hypothesis 4: Age influences the promptness to use apps. 
H0 – People over 65 will tend to score low on the component Promptness. 
H1 – People over 65 will tend to score high on the component Promptness. 
 
It is possible to reject H0 since the Spearman Test significance is p <0.001 and a 
component correlation of -0.322 which means that H1 is true, so age influences the 
promptness of app use and it is inversely proportional.  
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Hypothesis 5: Education Level influences the ability to use apps. 
H0 – People with level of education of bachelor’s degree or above will tend to score 
low on the component Ability. 
H1 – People with level of education of bachelor’s degree or above will tend to score 
high on the component Ability. 
 
It is not possible to reject H0 since the Mann- Whitney Test significance was p = 0.055 
which means that H1 is false thus, there is no influence of education level on the Ability 
of app use. 
 
Hypothesis 6: Education Level influences the promptness to use apps. 
H0 – People with level of education of bachelor’s degree or above will tend to score 
low on the component Promptness. 
H1 – People with level of education of bachelor’s degree or above will tend to score 
high on the component Promptness. 
 
It is not possible to reject H0 since the Mann- Whitney Test significance was p = 0.108 
which means that H1 is false thus, there is no influence of education level on the Ability 
of app use. 
 
Hypothesis 7: Health literacy is influenced by education level. 
H0 – Almost always adequate literacy is not related with a level of education of bachelor’s 
degree or above. 
H1- Almost always adequate literacy is related with a level of education of bachelor’s 
degree or above. 
 
It is not possible to reject H0 since the Chi-Square Test significance is 0,057 which 
means that H1 is false, so having almost always adequate literacy is not related with a 
level of education of bachelor’s degree or above.  
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Chapter 6 - Discussion 
 
Throughout this study it was possible to get different perspectives on the use of 
apps as a replacement to face to face consultations as well as the limitations healthcare 
professionals might encounter when trying to implement this service.   
 
 The number of studies concerning this subject are still very few, and data is very 
scarce when it comes to the application of mobile and digital health (Bull, 2016; World 
Health Organization, 2016). Hence the importance of conducting this type of study to 
assess not only the majority of population but also populational groups for example, older 
populations, minorities, low-income communities along with others. Several studies 
showed that mHealth can be helpful when it comes to prevention, however, it lacks the 
strong evidence to support this claim and it is still unknown which consequences it might 
have in long term use (Vodopivec-Jamsek, de Jongh, Gurol-Urganci, Atun, & Car, 2012). 
 
6.1 - Collected Data  
 Most respondents belonged to the Young age group (<65years old), the youngest 
being 34 and the mean age being 61 years old.  
 
Previous literature suggested a greater percentage of male could be  expected , 
which was corroborated by our findings (Sanchis-Gomar, Perez-Quilis, Leischik, & 
Lucia, 2016). It was also expectable that most people were from the east of London given 
the location of the hospital, which was confirmed by our findings. The most prevalent 
ethnicity was being White (48%) and the most common mother tongue was English, 
concordant with the general ethnic and language description of the London population.  
 
As expected, based on the W.H.O. Global eHealth Diffusion Report, 76% of 
respondents had a smartphone of which 70% knew how to use a smartphone making it 
easy for a Healthcare professional to apply the app as secondary prevention follow-up. 
Plus, even for those who do not know how to use an app, it would be possible to be given 
the support on how to use it which 81% of respondents agreed would make them willing 
to use the app (World Health Organization, 2016). 
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Also, respondents seemed keen on being empowered to take part in their health as  
the majority of respondents were willing to go for blood tests when needed (92%) and the 
majority of those who did not own a BP machine, were willing to buy one to self-monitor 
their blood pressure, and subsequently enter the data into the app making it available to 
the clinician. 
 
Most respondents believed they had the technological skills to use a smartphone, 
which most use on a daily basis making it easy to implement an app for secondary 
prevention follow-up.  
Plus, respondents seemed interested in having an app as a follow-up replacement 
as most stated they would like to have an app to monitor their condition and agree that 
having access to a healthcare professional through an app would have a great impact on 
their health. Additionally, having a specialist from the hospital, even if remotely, was 
considered important by nearly all the respondents.   
Not only would the app allow a more frequent and quicker follow-up, which was 
perceived by most respondents, it would allow patient to have access to a cardiac 
specialist from the hospital. The model for remote monitoring was the question generating 
most hesitancy 34% were undecided if they would prefer video or face to face 
consultations.  
 
6.2 - Hypothesis and Research Questions Interpretation  
All the hypothesis formulated were analysed and a conclusion was reached in 
order to answer the research questions presented. Through analysing the results attained 
from the hypothesis formulation, it is fair to say that the strongest relation found was 
age’s influence on ability and promptness to use the virtual clinic app.  
Hypothesis 1 and 2 showed gender had no influence on the respondents’ 
willingness to use an app. ´ 
Hypothesis 3 and 4 showed a strong influence of age on the willingness to use an 
app as secondary prevention follow-up being inversely proportional so younger people 
would tend to agree more with using an app.  
With hypothesis 5, 6 and 7, it was expected to find a correlation between 
Education Level and Ability, Promptness and Health and Digital Literacy. However, 
these were statistically non-significant showing no relation between these variables.  
Research Questions 
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Does gender influence the willingness to use an app?  
As shown with hypothesis 1 and 2, there is no relation between the variables. 
 
Does age influence the promptness of using an app? 
As shown with hypothesis 3, age is inversely proportional to the promptness to use 
apps. 
 
Does age influence the ability of using an app? 
As shown with hypothesis 4, age is inversely proportional to the ability to use apps. 
 
Does education influence the promptness of using an app? 
As shown with hypothesis 5, education level has no relation with the promptness to use 
apps. 
 
Does education influence the ability to use an app? 
As shown with hypothesis 6, education level has no relation with the ability to use apps. 
 
Does educational level influence digital and health literacy? 
As shown with hypothesis 7, Education Level does not influence Digital and Health 
Literacy. 
 
Do patients deem the app an equivalent substitute to face to face consultations? 
The model for remote monitoring was the question generating most hesitancy 34% were 
undecided if they would prefer video or face to face consultations.  
 
Are patients willing to help the clinician with the data needed for a follow-up 
consultation? 
Research showed that the majority of respondents were willing to help the clinician 
going for blood tests when needed. Also, for the majority those who did not own a BP 
machine were willing to buy one to monitor their blood pressure. 
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6.3 - Study Limitations and Practical Implications 
Although this study is valuable in its innovative approach to health care, trying to 
place the patient at the center of the decision-making process, it also has some limitations 
worth acknowledging. Some of the limitations were associated with the limited data 
collection time and the fact that data collection was restricted to one single site, making 
the sample size dependent of new incoming patients to the ward. In addition, although the 
questionnaire was subject to a brief validation process, full validation would probably 
lead to higher validity and reliability of the measurement tool. Also, the fact that data was 
collected using a questionnaire, instead of observation methods for instance, is inevitably 
associated with potentially dishonest answers, including social desirability bias. The fact 
that the survey was self-administered also contributes to potential low exhaustiveness of 
answers, with the possibility of getting blank questions.    
The use of the NVS score, despite being a validated screening tool, lead to 
difficulties in the application of the survey tool. In fact, the research team felt respondents 
found this section of the questionnaire hard and confusing to answer. 
 This study allows a broader perspective on how apps would be accepted by 
patients. In a practical setting, not everyone would have the possibility or ability to have 
access to this Virtual Clinic app although as established by the W.H.O., mHealth should 
be accessible to everyone. In the long run, this app could be beneficial to hospitals and 
healthcare professional since it is less time consuming than face to face consultations, 
decreasing hospital waiting times and releasing healthcare professional’s time to other 
equally important matters. On a patient point of view, it would not only be a comfortable 
and easy approach to health management, but it would also make the patient more aware 
of their symptoms, BP measurements, blood test results along with others. Since patient 
centered care is the approach that should be taken, having an app to monitor their 
condition would empower patients to take care of their health. 
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Chapter 7 - Conclusion 
This study emerged from the need to assess the feasibility of having a mobile 
application to follow up a patient subsequently to a hospital admission caused by a MI. 
The development of the questionnaire allowed the team to collect information 
specific to the area of London which is beneficial in an early stage since the Ortus iHealth 
project is being piloted at St. Bartholomew’s Hospital. 
This study suggests having a Virtual Clinic app is potentially interesting to 
enhance the quality of secondary prevention therapy follow-up and is a service likely to 
be accepted by patients. 
Future work should focus on the acceptability of these innovative technologies 
also by healthcare professionals. 
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Appendix I - Virtual Clinics Assessment Questionnaire  
 
VIRTUAL CLINICS ASSESSEMENT 
This questionnaire has been developed to assess barriers and enablers of follow-
up using virtual clinics, after a heart attack. Ortus-iHealth is a smartphone app 
that was developed to empower patients and increase communication between 
healthcare professionals and patients.  
 
After a heart attack, patients we aim to follow up in an outpatient clinic 
appointment within 3-6 months, due to capacity this can be challenging.  Using 
this app, healthcare professionals are able to give a personalized care through 
regular follow-up in a virtual clinic and monitor patient’s condition more closely. 
 
This questionnaire shouldn’t take more than 5-10 minutes.   
 
1. Age:_____ 
 
2. Gender: 
□ Female 
□ Male 
□ Other 
 
3. First three letters of post code: ___________ 
 
4. Ethnic origin:  
White 
- English / Welsh / Scottish / Northern Irish / British ................................  □ 
- Irish ......................................................................................................... □ 
Mixed / Multiple ethnic groups 
- White and Black Caribbean .................................................................... □ 
- White and Black African ......................................................................... □ 
- White and Asian ..................................................................................... □ 
Asian / Asian British 
- Indian ...................................................................................................... □ 
- Pakistani ................................................................................................. □ 
- Bangladeshi ............................................................................................ □ 
- Chinese .................................................................................................. □ 
Black  
- African .................................................................................................... □ 
- Black British ............................................................................................ □ 
- Caribbean ............................................................................................... □ 
□ Arab 
□ any other ethnic group. Which?_______________________________ 
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5. Education: 
□ Less than a high school diploma 
□ High school degree or equivalent 
□ Bachelor’s degree 
□ Master’s degree 
□ Doctorate 
□ Other: ________________________________________________________ 
 
 
6. Are you accompanied/ cared for by a family member or a carer? 
□Yes. Which? ___________________________________________________ 
□No 
 
7. Employment status:  
□ Employed for wages 
□ Self-employed 
□ Out of work and looking for work 
□ Out of work but not currently looking for work 
□ Retired 
□ Unable to work 
□ Other. Which?__________________________________________________ 
 
8. Language(s) spoken at home (if answer is English, skip question 9):  
□ English  □ Other: ________________________________________ 
 
9. If you answered “Other” in question 8, how well do you speak English? 
□ Very well   □ Well   □ Not well   □ Not at all  
 
10. Do you have a smartphone? 
□Yes 
□No 
 
11. If you answered “No” on question 10, do you have someone at home 
who can help you use a smartphone and apps?  
□Yes 
□No 
 
Please answer the following statements, indicating your level of agreement with 
each of them. 
12. I have the technological skills to use a smartphone. 
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
13. I use my smartphone regularly, on a daily basis. 
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
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14.  I am familiar with smartphone applications (app).  
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
15. I find apps hard to use so I don’t have any on my smartphone. 
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
16.  I use apps frequently.   
□ Daily □ Weekly □Monthly □ Once a week □ Never 
 
17. I use my smartphone/computer to research health related subjects on 
the internet.  
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
18. I have Health Apps installed on my smartphone.  
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
19. I would be happy to have an app to monitor and support my condition.  
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
20. I believe that having access to a healthcare professional through an 
app would have a great impact on my health. 
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
21. I would prefer being followed-up by a cardiac specialist from hospital 
than my general practitioner (GP). 
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
22.  A consultation through an app (video consultation) would more be 
acceptable compared to a face to face appointment. 
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
23. Having regular follow-up from a specialist is important to me following 
my hospital admission.  
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
24. I would be happy for my specialist follow-up care to take place through 
an app if it offered more frequent or quicker follow up.  
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□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
25. I would be willing to use an app if I was given support on how to use it.  
□ Strongly agree □ Agree □Undecided □ Disagree □ Strongly disagree 
 
26. Do you own a blood pressure machine? 
□Yes 
□No 
 
27. If you answered “NO” on question 26, a blood pressure machine costs 
around £20, would you be willing to buy one if it was beneficial for your 
health? 
□Yes 
□No 
28. Are you willing to go to your GP for blood tests? 
□Yes 
□No 
 
This information is on the back of a container of a pint of ice cream. Please 
answer the six following questions based on the picture.  
 
1. If you eat the entire container, how 
many calories are you eating? 
______________ 
 
2. You are allowed to eat 60g of 
carbohydrates as a snack, how much 
ice cream can you have? 
_________________ 
 
3. You have 42g of saturated fat each day 
which includes one serving of ice 
cream. If you stop eating the ice cream, 
how many grams of saturated fat would 
you have? 
_____________________________ 
  
4. If you usually eat 2,500 calories in a day, 
what percentage of this will you be 
eating if you eat one serving of ice 
cream? __________________________ 
 
5. Imagine you are allergic to penicillin, peanuts, latex gloves and bee 
stings. Is it safe to eat this ice cream? _____________ 
 
6. If you answered NO, why not? 
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     __________________________ 
 
Thank you for your time. 
Comments: 
 
 
 
 
 
 
 
 
 
 
 
 
NVS Health Literacy Score: _____ 
  



